Strategies for the reduction of misfolded tau-mediated AD neuropathology are directed to correct a loss of tau function resulting from sequestration of cellular tau and minimize possible gain-of-function toxicities caused by multimeric tau species [10]. Here, MAPT is linked to Alzheimer disease.